دورية أكاديمية

Oxaliplatin and 5-FU/folinic acid (modified FOLFOX6) with or without aflibercept in first-line treatment of patients with metastatic colorectal cancer: the AFFIRM study

التفاصيل البيبلوغرافية
العنوان: Oxaliplatin and 5-FU/folinic acid (modified FOLFOX6) with or without aflibercept in first-line treatment of patients with metastatic colorectal cancer: the AFFIRM study
المؤلفون: Folprecht, G. *, Pericay, C., Saunders, M.P., Thomas, A., Lopez Lopez, R., Roh, J.K., Chistyakov, V., Höhler, T., Kim, J.-S., Hofheinz, R.-D., Ackland, S.P., Swinson, D., Kopp, M., Udovitsa, D., Hall, M., Iveson, T., Vogel, A., Zalcberg, J.R.
المصدر: In Annals of Oncology July 2016 27(7):1273-1279
قاعدة البيانات: ScienceDirect
الوصف
تدمد:09237534
DOI:10.1093/annonc/mdw176